Nicholas Company, Inc.’s Boston Scientific Corp Position
Does Nicholas Company, Inc. own Boston Scientific Corp (BSX)? Yes — 741.3K shares worth $47M (+0.91% of its 13F portfolio) as of Q1 2026, up from 627.2K shares the prior filed quarter.
Position Value
$47M
Q1 2026
Shares
741.3K
% of Portfolio
+0.91%
Quarters Held
30
currently held
Position History BSX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 741.3K | $47M | +0.91% |
| Q4 2025 | 627.2K | $60M | +1.05% |
| Q3 2025 | 627.2K | $61M | +1.04% |
| Q2 2025 | 627.2K | $67M | +1.13% |
| Q1 2025 | 627.2K | $63M | +1.10% |
| Q4 2024 | 712.2K | $64M | +1.03% |
| Q3 2024 | 736.7K | $62M | +1.00% |
| Q2 2024 | 900.6K | $69M | +1.15% |
| Q1 2024 | 1.11M | $76M | +1.26% |
| Q4 2023 | 1.11M | $64M | +1.14% |
| Q3 2023 | 1.11M | $59M | +1.18% |
| Q2 2023 | 1.11M | $60M | +1.15% |
| Q1 2023 | 1.11M | $56M | +1.13% |
| Q4 2022 | 1.11M | $52M | +1.10% |
| Q3 2022 | 1.11M | $43M | +0.99% |
| Q2 2022 | 1.11M | $42M | +0.91% |
| Q1 2022 | 1.12M | $49M | +0.88% |
| Q4 2021 | 1.12M | $48M | +0.78% |
| Q3 2021 | 1.12M | $49M | +0.86% |
| Q2 2021 | 1.12M | $48M | +0.84% |
| Q1 2021 | 1.12M | $43M | +0.81% |
| Q4 2020 | 1.07M | $38M | +0.73% |
| Q3 2020 | 968.0K | $37M | +0.78% |
| Q2 2020 | 968.3K | $34M | +0.78% |
| Q1 2020 | 968.1K | $32M | +0.89% |
| Q4 2019 | 937.9K | $42M | +0.89% |
| Q3 2019 | 937.8K | $38M | +0.86% |
| Q2 2019 | 937.8K | $40M | +0.90% |
| Q1 2019 | 938.0K | $36M | +0.85% |
| Q4 2018 | 945.9K | $33M | +0.87% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nicholas Company, Inc.’s full portfolio or all institutional holders of BSX.